Fragile-X-associated Tremor/Ataxia Syndrome (FXTAS) in a Female with FMR1 Premutation: Case Report
PDF
Cite
Share
Request
Case report
VOLUME: 32 ISSUE: 3
P: 488 - 491
2022

Fragile-X-associated Tremor/Ataxia Syndrome (FXTAS) in a Female with FMR1 Premutation: Case Report

Anatol J Gen Med Res 2022;32(3):488-491
1. Çanakkale Onsekiz Mart University Faculty of Medicine, Department of Neurology, Çanakkale, Turkey
2. Çanakkale Onsekiz Mart University Faculty of Medicine, Department of Medical Genetics, Çanakkale, Turkey
No information available.
No information available
Received Date: 2021-01-27T13:27:06
Accepted Date: 2022-12-05T14:35:31
PDF
Cite
Share
Request

Abstract

People carrying a fragile-X-mental retardation 1 (FMR1) expansion between 55 and 200 cytosine-guanine-guanine (CGG) repeats are at increased risk of the fragile-X-associated tremor/ataxia syndrome (FXTAS). FXTAS clinical findings are late-onset psychological disorders, cerebellar gait ataxia, cognitive decline, and cerebellar intentional tremor. About 8% of female and 75% of male FMR1 premutation carriers develop FXTAS. Due to the protective effect of the second X chromosome, FXTAS have rarely been observed in women extremely rare. We describe a sixty-eight-year-old female carrier of the FMR1 premutation who presented with symptoms of tremor and gait ataxia and whose son has mental retardation with fragile-X syndrome. Mild global brain atrophy and white-matter lesions were observed in the magnetic resonance imaging images. Genetic analysis confirmed the premutation with a number of 90 CGG repeats. FXTAS is a neurodegenerative disease with a premutation of the FMR1 gene. Female patients with gait ataxia and tremor should be referred for a genetic test with family members.

Keywords:
Frajil-X-ilişkili tremor/ataksi sendromu, kadın, FMR1 premutasyonu